15
1

Kana Enomoto keynote

  • Upload
    opunite

  • View
    413

  • Download
    0

Embed Size (px)

Citation preview

Page 1: Kana Enomoto keynote

1

Page 2: Kana Enomoto keynote

ADVANCING THE BEHAVIORAL HEALTH OF THE NATION:

AMERICA’S OPIOID CRISISKana Enomoto

Substance Abuse and Mental Health Services Administration

2016 National RX Drug Abuse & Heroin Summit Atlanta, GA • March 29, 2016

Page 3: Kana Enomoto keynote

3

NEONATAL ABSTINENCE SYNDROME

Page 4: Kana Enomoto keynote

4

Page 5: Kana Enomoto keynote

5

US death rates fell steadily until 1999

Case & Deaton. Rising morbidity and mortality in midlife among white Non-Hispanic Americans in the 21st century. PNAS [epub Nov 2, 2015].

Sweden

Australia

CanadaUK

USHispanics

Germany

France

US non-HispanicWhites

… but then began to increase

among middle-aged white Americans

Dea

ths

per 1

00,0

00 p

opul

atio

nag

es 4

5-54

OVERDOSE

Page 6: Kana Enomoto keynote

6

Page 7: Kana Enomoto keynote

7

OUR STRATEGY

1) Improving prescriber practices

2) Increasing the use of naloxone

3) Expanding access to MAT

Page 8: Kana Enomoto keynote

8

Improving Prescriber Practices

• NEW: SAMHSA SPF Rx Grants• $10,000,000• 20 States• PDMP data to prevent Rx Misuse

Page 9: Kana Enomoto keynote

9

INCREASING USE OF NALOXONE• NEW: SAMHSA

Prescription Drug Overdose Grants

• $12,000,000

• 10 States

• Purchase, Equip, Train

Page 10: Kana Enomoto keynote

10

NEW: Buprenorphine Notice of Proposed

Rulemaking

NEW: MAT Pocket Guide

EXPANDING ACCESS TO MAT

•NEW: SAMHSA Medication Assisted Treatment for Prescription Drug and Opioid Addiction (MAT-PDOA) Grants•$25,000,000•23 States•Focus on high-need communities

Page 11: Kana Enomoto keynote

11

OUR IMPACT

Page 12: Kana Enomoto keynote

12

Continuing education to over 72,000 primary care physicians, dentists, and other healthcare professionals

31,552 physicians with a waiver to prescribe buprenorphine for opioid dependence

Over 76,500 Downloads

OUR IMPACT

Page 13: Kana Enomoto keynote

13

PPW

OUR IMPACT

Page 14: Kana Enomoto keynote

14

OUR FUTURE

FY2017: $4.3B investment in SAMHSA +$590M

State Cooperative Agreements/Evaluation

Buprenorphine Prescribing Authority Demo

PPW Demo

Page 15: Kana Enomoto keynote

15